122 related articles for article (PubMed ID: 10831277)
1. Inhibition of Ras p21 synthesis by antisense undecamers with uniform and specifically arranged phosphorothioate linkages.
Rait A; Uhlmann E; Peyman A; Will DW; Chang EH
Anticancer Drugs; 2000 Mar; 11(3):181-91. PubMed ID: 10831277
[TBL] [Abstract][Full Text] [Related]
2. 3'-End conjugates of minimally phosphorothioate-protected oligonucleotides with 1-O-hexadecylglycerol: synthesis and anti-ras activity in radiation-resistant cells.
Rait A; Pirollo K; Will DW; Peyman A; Rait V; Uhlmann E; Chang EH
Bioconjug Chem; 2000; 11(2):153-60. PubMed ID: 10725091
[TBL] [Abstract][Full Text] [Related]
3. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.
Monia BP; Johnston JF; Sasmor H; Cummins LL
J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
5. Antisense inhibition of ras p21 expression that is sensitive to a point mutation.
Chang EH; Miller PS; Cushman C; Devadas K; Pirollo KF; Ts'o PO; Yu ZP
Biochemistry; 1991 Aug; 30(34):8283-6. PubMed ID: 1883816
[TBL] [Abstract][Full Text] [Related]
6. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
[TBL] [Abstract][Full Text] [Related]
7. Comparative inhibition of ras p21 protein synthesis with phosphorus-modified antisense oligonucleotides.
Chang EH; Yu Z; Shinozuka K; Zon G; Wilson WD; Strekowska A
Anticancer Drug Des; 1989 Oct; 4(3):221-32. PubMed ID: 2679622
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.
Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM
J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
10. 2',5'-linked oligo-3'-deoxyribonucleoside phosphorothioate chimeras: thermal stability and antisense inhibition of gene expression.
Bhan P; Bhan A; Hong M; Hartwell JG; Saunders JM; Hoke GD
Nucleic Acids Res; 1997 Aug; 25(16):3310-7. PubMed ID: 9241246
[TBL] [Abstract][Full Text] [Related]
11. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.
Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T
Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450
[TBL] [Abstract][Full Text] [Related]
12. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
13. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation.
Saison-Behmoaras T; Tocqué B; Rey I; Chassignol M; Thuong NT; Hélène C
EMBO J; 1991 May; 10(5):1111-8. PubMed ID: 1850694
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate oligonucleotides cause degradation of secretory but not intracellular serglycin proteoglycan core protein in a sequence-independent manner in human megakaryocytic tumor cells.
Schick BP; Eras JL; Mintz PS
Antisense Res Dev; 1995; 5(1):59-65. PubMed ID: 7613073
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by antisense oligodeoxynucleotides directed against K-ras.
Kawada M; Fukazawa H; Mizuno S; Uehara Y
Biochem Biophys Res Commun; 1997 Feb; 231(3):735-7. PubMed ID: 9070883
[TBL] [Abstract][Full Text] [Related]
16. Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells.
Daaka Y; Wickstrom E
Oncogene Res; 1990; 5(4):267-75. PubMed ID: 2204019
[TBL] [Abstract][Full Text] [Related]
17. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides.
Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M
Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770
[TBL] [Abstract][Full Text] [Related]
19. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM
J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
